WeVote
Log In

Bill

Bill

HB 648

relative to insurance coverage for glucose monitoring.

2025 Regular Session Introduced by Peggy Balboni and 11 co-sponsors

Bill HB 648 mandates insurance coverage for glucose monitoring devices, reducing costs for diabetes patients and improving access to essential health tools.

Minority Committee Report: Ought to Pass with Amendment # 2025-3059h
0
WeVote Research Nonpartisan
Bill Summary · HB 648

Summary of Bill HB 648: Insurance Coverage for Glucose Monitoring

Purpose and Intent

Bill HB 648 aims to enhance insurance coverage for glucose monitoring devices, which are essential for individuals managing diabetes. The bill seeks to ensure that patients have access to necessary monitoring tools, thereby improving health outcomes and potentially reducing long-term healthcare costs associated with diabetes complications.

Key Provisions

  • Insurance Coverage Requirements: The bill mandates that health insurance plans provide coverage for glucose monitoring devices, including continuous glucose monitors (CGMs) and traditional glucose meters.
  • Cost-Sharing Limits: It proposes to limit out-of-pocket costs for patients, making these devices more affordable and accessible.
  • Preventive Care Inclusion: The bill emphasizes that glucose monitoring should be considered a preventive care service, thereby reducing barriers to access for patients.
  • Amendment # 2025-3059h: The minority committee report includes specific amendments that may refine the coverage details or implementation timelines, although the exact changes are not specified in the summary.

Affected Parties

  • Patients with Diabetes: The primary beneficiaries of this bill are individuals diagnosed with diabetes who rely on glucose monitoring for effective disease management.
  • Healthcare Providers: Physicians and healthcare professionals will have clearer guidelines regarding the coverage of glucose monitoring devices, potentially improving patient care.
  • Insurance Companies: The bill will require adjustments in policy offerings and coverage plans to comply with the new mandates.

Legislative Timeline

  • Introduced: January 21, 2025
  • Public Hearing: January 29, 2025
  • Committee Work Sessions: Various sessions were held throughout 2025, culminating in an executive session on March 5, 2025.
  • Committee Reports:
    • On November 13, 2025, the minority committee reported that the bill ought to pass with amendments, while the majority committee recommended it for interim study.
  • Next Steps: The bill's future will depend on further legislative action following the committee reports.

Conclusion

Bill HB 648 represents a significant step towards improving healthcare access for individuals with diabetes by ensuring that necessary glucose monitoring devices are covered by insurance. The ongoing discussions and amendments will shape the final form of the legislation and its implementation.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.